One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The Overall Survival Benefit in EV-302: Is Enfortumab Vedotin plus Pembrolizumab the New Frontline Standard of Care for Metastatic Urothelial Carcinoma?
David J. Benjamin a, Arash Rezazadeh Kalebasty b, Vinay Prasad c
doi : 10.1016/j.euo.2024.02.010
Volume 7, Issue 3, June 2024, Pages 313-315
Real-life Perioperative Outcomes of Radical Prostatectomy using the French National Registry: A Plea for Promotion of Centralized Care and Access to Minimally Invasive Approaches
Michael Baboudjian a, Annabelle Grabia b, Eric Barret c, Romain Mathieu d, François Rozet c, Charles-Edouard Lequeu b, Morgan Rouprêt e, Guillaume Ploussard f g
doi : 10.1016/j.euo.2023.10.006
Volume 7, Issue 3, June 2024, Pages 316-318
Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma
Felix Seelemeyer a, David Pfister a, Roberto Pappesch c, Sabine Merkelbach-Bruse c, Pia Paffenholz a, Axel Heidenreich a b
doi : 10.1016/j.euo.2023.10.021
Volume 7, Issue 3, June 2024, Pages 319-322
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort Study
Riccardo Campi a b c, Alessio Pecoraro a, Eduard Roussel d, Daniele Amparore e, Andrea Mari b f, Francesco Montorsi g h, Francesco Porpiglia e, Maarten Albersen d, Umberto Capitanio g h, Andrea Minervini b f, Sergio Serni a b, Riccardo Bertolo i
doi : 10.1016/j.euo.2023.10.023
Volume 7, Issue 3, June 2024, Pages 323-327
On-treatment Modified Glasgow Prognostic Score Provides Predictive Information Complementary to Radiological Staging in Metastatic Urothelial Carcinoma on Immunotherapy
Jonas Saal a b c, Viktor Grünwald d, Tobias Bald b c, Manuel Ritter c e, Peter Brossart a c, Yoshihiko Tomita f, Arndt Hartmann g h i, Michael Hölzel b c, Markus Eckstein g h i †, Niklas Klümper b c e â€
doi : 10.1016/j.euo.2023.11.005
Volume 7, Issue 3, June 2024, Pages 328-331
Sexual Structure Sparing for Prostate Cancer Radiotherapy: A Systematic Review
Jennifer Le Guevelou a, Paul Sargos b, Ludovic Ferretti c, Stephane Supiot d, David Pasquier e, Gilles Créhange f, Pierre Blanchard g, Christophe Hennequin h, Olivier Chapet i, Ulrike Schick j, Manon Baty a, Ingrid Masson a, Guillaume Ploussard k l, Renaud De Crevoisier a, Igor Latorzeff m
doi : 10.1016/j.euo.2023.08.003
Volume 7, Issue 3, June 2024, Pages 332-343
Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer
Martin Schostak a, Angela Bradbury b, Alberto Briganti c, David Gonzalez d, Leonard Gomella e, Joaquin Mateo f, Frédérique Penault-Llorca g, Albrecht Stenzinger h, Alexander W. Wyatt i, Anders Bjartell j k
doi : 10.1016/j.euo.2023.08.004
Volume 7, Issue 3, June 2024, Pages 344-354
Local Therapy on Clinically Lymph Node–positive Prostate Cancer: A Systematic Review and Meta-analysis
Clyve Yu Leon Yaow a †, Han Jie Lee b †, Seth En Teoh a, Ryan Ian Houe Chong a, Tze Kiat Ng b, Kae Jack Tay b, Henry Ho b, Yan Mee Law c, Jeffrey Tuan d, John Yuen b, Kenneth Chen b
doi : 10.1016/j.euo.2023.09.002
Volume 7, Issue 3, June 2024, Pages 355-364
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis
Tamás Fazekas a b, �dám D. Széles a b, Brigitta Teutsch b c, Anita Csizmarik a, Bálint Vékony a, Tamás Kói b d, Nándor �cs b e, Péter Hegyi b c f, Boris Hadaschik g, Péter Nyirády a b, Tibor Szarvas a g
doi : 10.1016/j.euo.2023.09.001
Volume 7, Issue 3, June 2024, Pages 365-375
Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis
Akihiro Matsukawa a b, Takafumi Yanagisawa a b, Kensuke Bekku a c, Mehdi Kardoust Parizi a d, Ekaterina Laukhtina a e, Jakob Klemm a f, Sever Chiujdea a g, Keiichiro Mori a b, Shoji Kimura a b, Jun Miki b, Benjamin Pradere a h, Juan Gomez Rivas i, Giorgio Gandaglia j, Takahiro Kimura b, Veeru Kasivisvanathan k l, Guillaume Ploussard h, Philip Cornford m, Shahrokh F. Shariat a e n o p q r, Pawel Rajwa a s
doi : 10.1016/j.euo.2023.10.010
Volume 7, Issue 3, June 2024, Pages 376-400
Clinical Application of Digital and Computational Pathology in Renal Cell Carcinoma: A Systematic Review
Zine-Eddine Khene a b c, Solène-Florence Kammerer-Jacquet b d, Pierre Bigot e, Noémie Rabilloud b, Laurence Albiges f, Vitaly Margulis c, Renaud De Crevoisier f, Oscar Acosta b, Nathalie Rioux-Leclercq d, Yair Lotan c, Morgan Rouprêt g, Karim Bensalah a
doi : 10.1016/j.euo.2023.10.018
Volume 7, Issue 3, June 2024, Pages 401-411
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?
Amanda A. Myers a, Alberto Briganti b, Bradley Leibovich c, Seth P. Lerner d, Marco Moschini b, Morgan Rouprêt e, Shahrokh F. Shariat f, Philippe E. Spiess g, Arnulf Stenzl h, Samir S. Taneja i, Karim A. Touijer j, Ashish M. Kamat a
doi : 10.1016/j.euo.2023.10.028
Volume 7, Issue 3, June 2024, Pages 412-420
Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study
Mona Kafka a, Andreas Horninger a, Gianpaolo di Santo b, Irene Virgolini b, Hannes Neuwirt c, Lena M. Unterrainer d, Sophie C. Kunte d, Emil Deiss e, Pia Paffenholz e, Axel Heidenreich e, Sazan Rasul f, Holger Einspieler f, Shahrokh F. Shariat g h i j k l m n o, Pawel Rajwa n o, Robert Dozauer p, Igor Tsaur p, Ellen Medlock p, Niklas Rölz p, Steffen Rausch q, Christian la Fougère r…Isabel Heidegger a
doi : 10.1016/j.euo.2023.07.018
Volume 7, Issue 3, June 2024, Pages 421-429
Impact of Relative Volume Difference Between Magnetic Resonance Imaging and Three-dimensional Transrectal Ultrasound Segmentation on Clinically Significant Prostate Cancer Detection in Fusion Magnetic Resonance Imaging–targeted Biopsy
Louis Lenfant a b c, Clément Beitone b, Jocelyne Troccaz b, Aurélien Beaugerie a, Morgan Rouprêt a, Thomas Seisen a, Raphaele Renard-Penna d, Sandrine Voros b, Pierre C. Mozer a c
doi : 10.1016/j.euo.2023.07.016
Volume 7, Issue 3, June 2024, Pages 430-437
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non–muscle-invasive Bladder Cancer
Kang Liu a, Hongda Zhao a, Xuan Chen a, Rossella Nicoletti a b, Nikhil Vasdev c d, Peter Ka-Fung Chiu a, Chi-Fai Ng a, Tatsushi Kawada e, Ekaterina Laukhtina f, Keiichiro Mori g, Takafumi Yanagisawa f g, David D'Andrea f, Markus von Deimling h, Simone Albisinni i, Wojciech Krajewski j, Benjamin Pradere f k, Francesco Soria l, Marco Moschini m, Dmitry Enikeev f n o p, Shahrokh Shariat f n o q r s v…Jeremy Yuen-Chun Teoh a
doi : 10.1016/j.euo.2023.09.014
Volume 7, Issue 3, June 2024, Pages 438-446
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study
Nuria Romero-Laorden a b †, David Lorente c †, Guillermo de Velasco d e, Rebeca Lozano f, Bernardo Herrera g h, Javier Puente i, Pedro P. López j, Ana Medina k, Elena Almagro l, Enrique Gonzalez-Billalabeitia d e, Jose Carlos Villla-Guzman m, Aránzazu González-del-Alba n, Pablo Borrega o, Nuria LaÃnez p, Ana Fernández-Freire q, Amaia Hernández r, Alejo Rodriguez-Vida s, Isabel Chirivella t, Eva Fernandez-Parra u, Fernando López-Campos v…David Olmos d j
doi : 10.1016/j.euo.2023.09.015
Volume 7, Issue 3, June 2024, Pages 447-455
Magnetic Resonance Imaging–Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE)
Laurence Klotz a, Joseph Chin b, Peter C. Black c, Antonio Finelli d, Maurice Anidjar e, Ashley Machado c, Mark Levental e, Sangeet Ghai d, Silvia D. Chang c, Chirag Patel f, Zahra Kassam b, Andrew Loblaw d, Marlene Kebabdjian a, Greg Pond g, Masoom A. Haider f
doi : 10.1016/j.euo.2023.09.013
Volume 7, Issue 3, June 2024, Pages 456-461
PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
Piet Ost a b, Shankar Siva c d e, Sigmund Brabrand f, Piet Dirix b, Nick Liefhooghe g, François-Xavier Otte h, Alfonso Gomez-Iturriaga i, Wouter Everaerts j, Mohamed Shelan k, Antonio Conde-Moreno l, Fernando López Campos m, Alexandros Papachristofilou n, Matthias Guckenberger o, Marta Scorsetti p, Almudena Zapatero q, Ana-Elena Villafranca Iturre r, Clara Eito s, Felipe Couñago t u, Paolo Muto v, Lien Van De Voorde w…Thomas Zilli x y bb cc
doi : 10.1016/j.euo.2023.09.007
Volume 7, Issue 3, June 2024, Pages 462-468
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
Andrew Weickhardt a, Farshad Foroudi a, Nathan Lawrentschuk b, Jing Xie c, Mark Sidhom d, Abhijit Pal d, Peter Grimison e, Alison Zhang e, Siobhan Ng f, Colin Tang f, Elizabeth Hovey g, Colin Chen g, George Hruby h, Alexander Guminski h, Margaret McJannett i, Ciara Conduit b i, Ben Tran b, Ian D. Davis i j k, Dickon Hayne l
doi : 10.1016/j.euo.2023.09.011
Volume 7, Issue 3, June 2024, Pages 469-477
Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis
Laura Elst a b †, Manon T.A. Vreeburg c †, Hielke Martijn de Vries b c, Kaat Vandermaesen a, Titus Murphy d, James Churchill e, Giuseppe Fallara b f g, Darren Sanchez h, Marco Falcone i, Herney Andres Garcia-Perdomo j, Curtis Pettaway h, Oliver Hakenberg k, Peter Johnstone l, Philippe E. Spiess l, Asif Muneer f, Vijay Sangar e, Arie Parnham e, Benjamin Ayres d, Nick Watkin d, Oscar R. Brouwer c ‡…Maarten Albersen a ‡
doi : 10.1016/j.euo.2023.09.005
Volume 7, Issue 3, June 2024, Pages 478-484
Digital Tracking of Patients Undergoing Radical Cystectomy for Bladder Cancer: Daily Step Counts Before and After Surgery Within the iROC Randomised Controlled Trial
Pramit Khetrapal a b, Parasdeep S. Bains c, Ibrahim Jubber c d, Gareth Ambler e, Norman R. Williams f, Chris Brew-Graves g, Ashwin Sridhar b, Anthony Ta b, John D. Kelly a b, James W.F. Catto a c d, iROC Study Team â€
doi : 10.1016/j.euo.2023.09.021
Volume 7, Issue 3, June 2024, Pages 485-493
Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR (CCAFU-PR2) Phase 2 Trial Rationale and Protocol
Giorgio Calleris a b, Thomas Filleron c, Claudia Kesch a d, Guilhem Roubaud e, Benjamin Pradère a, Bastien Cabarrou c, Bernard Malavaud f, Morgan Roupret g, Loic Mourey h, Guillaume Ploussard a f
doi : 10.1016/j.euo.2023.09.020
Volume 7, Issue 3, June 2024, Pages 494-500
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura a b, Matthew S. Ernst a, Vishal Navani a, J. Connor Wells c, Ziad Bakouny d, Frede Donskov e f, Naveen S. Basappa g, Lori A. Wood h, Luis Meza i, Sumanta K. Pal i, Bernadett Szabados j, Thomas Powles j, Benoit Beuselinck k, Rana R. McKay l, Jae-Lyun Lee m, D. Scott Ernst n, Anil Kapoor o, Takeshi Yuasa b, Toni K. Choueiri d, Daniel Y.C. Heng a
doi : 10.1016/j.euo.2023.10.002
Volume 7, Issue 3, June 2024, Pages 501-508
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate–Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study
Evan Y. Yu a, William R. Berry b, Howard Gurney c, Margitta Retz d, Henry J. Conter e, Brigitte Laguerre f, Peter C.C. Fong g, Cristiano Ferrario h, Tilman Todenhöfer i, Gwenaelle Gravis j, Josep M. Piulats k, Urban Emmenegger l, Neal D. Shore m, Emanuela Romano n, Loic Mourey o, Xin Tong Li p, Christian H. Poehlein q, Charles Schloss q, Leonard J. Appleman r, Johann S. de Bono s
doi : 10.1016/j.euo.2023.10.008
Volume 7, Issue 3, June 2024, Pages 509-518
Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial
Erin L. Van Blarigan a b c, Stacey A. Kenfield a b c, Adam Olshen b c, Neil Panchal d, Katriel Encabo a, Imelda Tenggara a, Rebecca E. Graff b, Alexander S. Bang a e, Katsuto Shinohara a, Matthew R. Cooperberg a b c, Peter R. Carroll a c, Lee W. Jones f, Kerri Winters-Stone g, Anthony Luke d, June M. Chan a b c
doi : 10.1016/j.euo.2023.10.012
Volume 7, Issue 3, June 2024, Pages 519-526
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer
Ludovic Bigot a †, Jonathan Sabio a †, Loic Poiraudeau a †, Maxime Annereau b, Naoual Menssouri a, Carole Helissey c, Olivier Déas d, Marine Aglave e, Tony Ibrahim a, Cédric Pobel a, Catline Nobre a, Claudio Nicotra f, Maud Ngo-Camus f, Ludovic Lacroix g h, Etienne Rouleau g h, Lambros Tselikas i, Jean-Gabriel Judde d, Anne Chauchereau a, Alice Bernard-Tessier j, Anna Patrikidou j…Yohann Loriot a f j
doi : 10.1016/j.euo.2023.10.011
Volume 7, Issue 3, June 2024, Pages 527-536
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office
Joost L. Boormans a, Richard Sylvester b, Lynn Anson-Cartwright c, Rachel M. Glicksman d, Robert J. Hamilton c, Ezra Hahn e, Gedske Daugaard f, Jakob Lauritsen f, Thomas Wagner f, Barbara Avuzzi g, Nicola Nicolai h, Xavier GarcÃa del Muro i, Jorge Aparicio i, Odile Stalder j, Christian Rothermundt k, Stefanie Fischer k, M. Pilar Laguna l
doi : 10.1016/j.euo.2023.10.014
Volume 7, Issue 3, June 2024, Pages 537-543
Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer
James P. Buteau a b, Daniel Moon c d, Michael T. Fahey b e, Matthew J. Roberts f g, James Thompson h, Declan G. Murphy b c, Nathan Papa i, Catherine Mitchell b j, Richard De Abreu Lourenco k, Haryana M. Dhillon l, Veeru Kasivisvanathan c m, Roslyn J. Francis n o, Phillip Stricker p q, Shihka Agrawal r s, Jonathan O'Brien b c, Aoife McVey b c, Gaurav Sharma a, Sidney Levy a b t u, Narjess Ayati r s, Andrew Nguyen r s…Louise Emmett r s â€
doi : 10.1016/j.euo.2023.11.008
Volume 7, Issue 3, June 2024, Pages 544-552
Men’s Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy
Rebecka Arnsrud Godtman a b, Christina Pettersson c d, Linda Svensson a b, Kimia Kohestani a b, Karin Stinesen Bratt a, Jonas Wallström c d, Marianne Månsson a, Mikael Hellström c d, Jonas Hugosson a b
doi : 10.1016/j.euo.2023.11.003
Volume 7, Issue 3, June 2024, Pages 553-562
The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality
Benjamin V. Stone a b c, Muhieddine Labban a b, Edoardo Beatrici a b, Dejan K. Filipas a b, Anthony V. D'Amico d, Stuart R. Lipsitz b, Toni K. Choueiri e, Adam S. Kibel a, Alexander P. Cole a b, Hari S. Iyer f, Quoc-Dien Trinh a b
doi : 10.1016/j.euo.2023.11.020
Volume 7, Issue 3, June 2024, Pages 563-569
Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies
Ghady Bou-Nehme Sawaya a, Alice Dragomir b, Lori A. Wood c, Christian Kollmannsberger d, Naveen S. Basappa e, Anil Kapoor f, Denis Soulières g, Antonio Finelli h, Daniel Y.C. Heng i, Vincent Castonguay j, Christina Canil k, Eric Winquist l, Jeffrey Graham m, Georg A. Bjarnason n, Bimal Bhindi i, Aly-Khan Lalani f, Frédéric Pouliot j, Rodney H. Breau k, Ramy Saleh o, Simon Tanguay o
doi : 10.1016/j.euo.2023.11.016
Volume 7, Issue 3, June 2024, Pages 570-580
The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study
David Leung a †, Daniele Castellani b †, Rossella Nicoletti a c d, Roser Vives Dilme e, Jesus Moreno Sierra e, Sergio Serni c d, Carmine Franzese b, Giuseppe Chiacchio b, Andrea Benedetto Galosi b, Roberta Mazzucchelli f, Erika Palagonia g, Paolo Dell'Oglio g, Antonio Galfano g, Aldo Massimo Bocciardi g, Xue Zhao h, Chi Fai Ng a, Hsiang Ying Lee i, Shinichi Sakamoto h, Nikhil Vasdev j, Juan Gomez Rivas e…Jeremy Yuen-Chun Teoh a
doi : 10.1016/j.euo.2023.12.006
Volume 7, Issue 3, June 2024, Pages 581-588
Postchemotherapy Retroperitoneal Lumpectomy in Patients with Nonseminoma Testicular Cancer: A Nationwide Study
Josephine Julie Rosenvilde a, Jakob Lauritsen a, Mikkel Bandak a, Thomas Wagner b, Mads Agerbæk c, Lars Dysager d, Mikael Aagaard e, Gedske Daugaard a
doi : 10.1016/j.euo.2023.12.004
Volume 7, Issue 3, June 2024, Pages 589-596
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients
Olivier Cussenot a b, Kirsten M. Timms c, Emmanuel Perrot d e, Pascal Blanchet d e, Laurent Brureau d e, Cara Solimeno c, Gaelle Fromont a f g, Eva Comperat a h, Geraldine Cancel-Tassin a i
doi : 10.1016/j.euo.2023.12.003
Volume 7, Issue 3, June 2024, Pages 597-604
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study
Christian Corsini a b, Oskar Bergengren a, Stefan Carlsson c, Hans Garmo a, Marie Hjelm-Eriksson d, Per Fransson e f, Jon Kindblom g, David Robinson h, Marcus Westerberg a, Pär Stattin a, Sigrid V. Carlsson i j k
doi : 10.1016/j.euo.2023.12.007
Volume 7, Issue 3, June 2024, Pages 605-613
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer
Roger Li a †, Luigi Nocera b †, Kyle M. Rose a, Daniele Raggi c, Shreyas Naidu a, Chiara Mercinelli c, Antonio Cigliola c, Valentina Tateo c, Damiano Patanè c, G. Daniel Grass a, Scott M. Gilbert a, Wade J. Sexton a, Marco Bandini b, Marco Moschini b, Alberto Briganti b c d, Francesco Montorsi b d, Philippe E. Spiess a ‡, Andrea Necchi a d ‡
doi : 10.1016/j.euo.2023.12.008
Volume 7, Issue 3, June 2024, Pages 614-624
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study
Hideaki Miyake a, Rikiya Matsumoto b, Kiyohide Fujimoto c, Atsushi Mizokami d, Hirotsugu Uemura e, Toshiyuki Kamoto f, Satoru Kawakami g, Kazuyoshi Nakamura h, Shigekatsu Maekawa i, Kazuhiro Shibayama j, Aki Watanabe k, Miku Ito l, Yohei Tajima l, Hideyasu Matsuyama m †, Hiroji Uemura n
doi : 10.1016/j.euo.2023.12.013
Volume 7, Issue 3, June 2024, Pages 625-632
Re: Raghav Gupta, Adriana M. Pedraza, Michael A. Gorin, Ashutosh K. Tewari. Defining the Role of Large Language Models in Urologic Care and Research. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.017
Amnuay Kleebayoon a, Viroj Wiwanitkit b
doi : 10.1016/j.euo.2023.09.022
Volume 7, Issue 3, June 2024, Page 633
Cost Effectiveness of Magnetic Resonance Imaging Guidance Versus Computed Tomography Guidance for Stereotactic Body Radiotherapy
Jacopo Giuliani a, Marta Mandarà  a, Francesco Fiorica b
doi : 10.1016/j.euo.2023.09.003
Volume 7, Issue 3, June 2024, Pages 634-635
Re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010
Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, Alberto Briganti
doi : 10.1016/j.euo.2023.10.020
Volume 7, Issue 3, June 2024, Page 636
Re: Katharina Brück, Richard P. Meijer, Joost L. Boormans, et al. Disease-free Survival of Patients with Muscle-invasive Bladder Cancer Treated with Radical Cystectomy Versus Bladder-preserving Therapy: A Nationwide Study. Int J Radiat Oncol Biol Phys. In press. https://doi.org/10.1016/j.ijrobp.2023.07.027
Giuseppe Basile a, Benjamin Pradere b c, Louis Lenfant d, Morgan Rouprêt d, Thomas Seisen d
doi : 10.1016/j.euo.2023.10.022
Volume 7, Issue 3, June 2024, Pages 637-638
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti’s Letter to the Editor re: David D’Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508–15
David D'Andrea a, Francesco Soria b, Rodolfo Hurle c, Dmitry Enikeev a d, Sergey Kotov e, Sophie Régnier f, Evanguelos Xylinas f, Lukas Lusuardi g, Axel Heidenreich h, Chao Cai i, Nicola Frego c, Mark Taraktin d, Maxim Ryabov j, Paolo Gontero b, Eva Compérat k, Shahrokh F. Shariat a l m n, for the eBLOC Study Team
doi : 10.1016/j.euo.2023.10.026
Volume 7, Issue 3, June 2024, Pages 639-640
Reply to Nikolaos Grivas, Christos Zampaftis, Dimitris Ermidis, Ioannis Leotsakos, Ioannis Katafigiotis, and Markos Karavitakis’s Letter to the Editor re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol 2023;6:399–405
David Pasquier a b, Thomas Lacornerie c
doi : 10.1016/j.euo.2023.11.010
Volume 7, Issue 3, June 2024, Page 641
Re: Kosuke Takemura, Matthew S. Ernst, Vishal Navani, et al. Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.002
Yudai Ishiyama a b, Fumihiko Urabe c
doi : 10.1016/j.euo.2023.12.011
Volume 7, Issue 3, June 2024, Pages 642-643
Re: Pawel Rajwa, Daniele Robesti, Michael Chaloupka, et al. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.006
Cem Onal a b, Aysenur Elmali b, Ozan Cem Guler a
doi : 10.1016/j.euo.2023.12.010
Volume 7, Issue 3, June 2024, Pages 644-645
Re: Hein V. Stroomberg, Signe Benzon Larsen, Torben Kjær Nielsen, J. Thomas Helgstrand, Klaus Brasso, Andreas Røder. Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.005
Giacomo Gallo, Riccardo Lombardo, Cosimo De Nunzio
doi : 10.1016/j.euo.2023.12.014
Volume 7, Issue 3, June 2024, Pages 646-647
